Long-Acting Injectable Antipsychotic Treatment in Schizophrenia and Co-occurring Substance Use Disorders: A Systematic Review

Objectives: Co-occurring substance use disorders (SUDs) among individuals with schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with increased symptom severity, worsened illness trajectory and high rates of treatment non-adherence. Recent evidence suggests that...

Descripción completa

Detalles Bibliográficos
Autores principales: Coles, Alexandria S., Knezevic, Dunja, George, Tony P., Correll, Christoph U., Kane, John M., Castle, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715086/
https://www.ncbi.nlm.nih.gov/pubmed/34975600
http://dx.doi.org/10.3389/fpsyt.2021.808002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715086/
https://www.ncbi.nlm.nih.gov/pubmed/34975600
http://dx.doi.org/10.3389/fpsyt.2021.808002

Ejemplares similares